1,2-dimethylhydrazine multiple interactions ISO RGD:1323277 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of BCAR3 mRNA CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:1323277 6480464 1, 2-Dimethylhydrazine results in decreased expression of BCAR3 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:36174057 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of BCAR3 mRNA CTD PMID:20660070 17beta-estradiol decreases expression ISO RGD:36174057 6480464 Estradiol results in decreased expression of BCAR3 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCAR3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCAR3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:36174057 6480464 Tetrachlorodibenzodioxin affects the expression of BCAR3 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCAR3 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1323277 6480464 Tetrachlorodibenzodioxin affects the expression of BCAR3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1323277 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCAR3 mRNA CTD PMID:19933214 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of BCAR3 mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:36174057 6480464 Lactic Acid results in increased expression of BCAR3 mRNA CTD PMID:30851411 4,4'-diaminodiphenylmethane decreases expression ISO RGD:1323277 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of BCAR3 mRNA CTD PMID:18648102 4-hydroxynon-2-enal decreases expression ISO RGD:1323277 6480464 4-hydroxy-2-nonenal results in decreased expression of BCAR3 mRNA CTD PMID:19191707 5-fluorouracil decreases expression ISO RGD:36174057 6480464 Fluorouracil results in decreased expression of BCAR3 protein CTD PMID:15352031 5-fluorouracil affects response to substance ISO RGD:36174057 6480464 BCAR3 protein affects the susceptibility to Fluorouracil CTD PMID:15352031 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of BCAR3 mRNA CTD PMID:24780913 , PMID:25825206 acetylsalicylic acid increases expression ISO RGD:36174057 6480464 Aspirin results in increased expression of BCAR3 mRNA CTD PMID:15928584 acrolein multiple interactions ISO RGD:36174057 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BCAR3 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of BCAR3 mRNA CTD PMID:32699268 adefovir pivoxil increases expression ISO RGD:36174057 6480464 adefovir dipivoxil results in increased expression of BCAR3 mRNA CTD PMID:25596134 afimoxifene multiple interactions ISO RGD:36174057 6480464 afimoxifene inhibits the reaction [Estrogens results in decreased expression of BCAR3 mRNA] CTD PMID:21233418 afimoxifene decreases response to substance ISO RGD:36174057 6480464 BCAR3 protein results in decreased susceptibility to afimoxifene CTD PMID:18351453 aflatoxin B1 increases methylation ISO RGD:36174057 6480464 Aflatoxin B1 results in increased methylation of BCAR3 intron CTD PMID:30157460 aflatoxin B1 increases expression ISO RGD:36174057 6480464 Aflatoxin B1 results in increased expression of BCAR3 mRNA CTD PMID:22100608 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BCAR3 mRNA CTD PMID:33354967 Aflatoxin B2 alpha decreases methylation ISO RGD:36174057 6480464 aflatoxin B2 results in decreased methylation of BCAR3 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:36174057 6480464 Tretinoin results in increased expression of BCAR3 mRNA CTD PMID:23724009 alpha-pinene multiple interactions ISO RGD:36174057 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BCAR3 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of BCAR3 mRNA CTD PMID:32699268 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of BCAR3 mRNA CTD PMID:30779732 aristolochic acid A increases expression ISO RGD:36174057 6480464 aristolochic acid I results in increased expression of BCAR3 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:36174057 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of BCAR3 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO RGD:36174057 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of BCAR3 mRNA CTD PMID:32525701 avobenzone increases expression ISO RGD:36174057 6480464 avobenzone results in increased expression of BCAR3 mRNA CTD PMID:31016361 benzo[a]pyrene decreases methylation ISO RGD:36174057 6480464 Benzo(a)pyrene results in decreased methylation of BCAR3 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:36174057 6480464 Benzo(a)pyrene affects the methylation of BCAR3 5' UTR, Benzo(a)pyrene affects the methylation of BCAR3 intron CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene diol epoxide I affects expression ISO RGD:36174057 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:36174057 6480464 7 more ... CTD PMID:19150397 bisphenol A decreases expression ISO RGD:36174057 6480464 bisphenol A results in decreased expression of BCAR3 mRNA CTD PMID:29275510 bisphenol A decreases methylation ISO RGD:36174057 6480464 bisphenol A results in decreased methylation of BCAR3 gene CTD PMID:31601247 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BCAR3 mRNA CTD PMID:19010381 cadmium dichloride increases expression ISO RGD:36174057 6480464 Cadmium Chloride results in increased expression of BCAR3 mRNA CTD PMID:25596134 caffeine decreases phosphorylation ISO RGD:36174057 6480464 Caffeine results in decreased phosphorylation of BCAR3 protein CTD PMID:35688186 carbon nanotube affects expression ISO RGD:1323277 6480464 Nanotubes, Carbon affects the expression of BCAR3 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:36174057 6480464 CGP 52608 promotes the reaction [RORA protein binds to BCAR3 gene] CTD PMID:28238834 chloroacetaldehyde increases expression ISO RGD:36174057 6480464 chloroacetaldehyde results in increased expression of BCAR3 mRNA CTD PMID:25596134 chloropicrin decreases expression ISO RGD:36174057 6480464 chloropicrin results in decreased expression of BCAR3 mRNA CTD PMID:26352163 , PMID:28476498 chloroprene increases expression ISO RGD:1323277 6480464 Chloroprene results in increased expression of BCAR3 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:1323277 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BCAR3 gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1323277 6480464 chromium hexavalent ion affects the expression of BCAR3 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:1323277 6480464 Ciguatoxins affects the expression of BCAR3 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:36174057 6480464 Cisplatin results in increased expression of BCAR3 mRNA CTD PMID:25596134 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BCAR3 mRNA CTD PMID:22023808 cisplatin multiple interactions ISO RGD:36174057 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of BCAR3 mRNA, Cisplatin affects the reaction [Piroxicam results in decreased expression of BCAR3 mRNA] CTD PMID:21858171 , PMID:27392435 cisplatin decreases expression ISO RGD:36174057 6480464 Cisplatin results in decreased expression of BCAR3 mRNA CTD PMID:19561079 cobalt dichloride decreases expression ISO RGD:36174057 6480464 cobaltous chloride results in decreased expression of BCAR3 mRNA CTD PMID:19320972 copper(II) sulfate increases expression ISO RGD:36174057 6480464 Copper Sulfate results in increased expression of BCAR3 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO RGD:36174057 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 crocidolite asbestos increases expression ISO RGD:36174057 6480464 Asbestos, Crocidolite results in increased expression of BCAR3 mRNA CTD PMID:18687144 crocidolite asbestos decreases expression ISO RGD:1323277 6480464 Asbestos, Crocidolite results in decreased expression of BCAR3 mRNA CTD PMID:29279043 CU-O LINKAGE decreases expression ISO RGD:36174057 6480464 cupric oxide results in decreased expression of BCAR3 mRNA CTD PMID:22077320 cyclosporin A increases expression ISO RGD:36174057 6480464 Cyclosporine results in increased expression of BCAR3 mRNA CTD PMID:20106945 more ... cytarabine decreases expression ISO RGD:36174057 6480464 Cytarabine results in decreased expression of BCAR3 mRNA CTD PMID:21198554 diclofenac decreases expression ISO RGD:1323277 6480464 Diclofenac results in decreased expression of BCAR3 mRNA CTD PMID:35537566 dioxygen increases expression ISO RGD:36174057 6480464 Oxygen deficiency results in increased expression of BCAR3 mRNA CTD PMID:25596134 dorsomorphin multiple interactions ISO RGD:36174057 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCAR3 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:36174057 6480464 Doxorubicin results in decreased expression of BCAR3 mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BCAR3 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:36174057 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of BCAR3 mRNA CTD PMID:19167446 fenofibrate decreases expression EXP 6480464 Fenofibrate results in decreased expression of BCAR3 mRNA CTD PMID:25596134 ferroheme b increases expression ISO RGD:1323277 6480464 Heme metabolite results in increased expression of BCAR3 mRNA CTD PMID:19191707 fluoranthene multiple interactions ISO RGD:1323277 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of BCAR3 mRNA CTD PMID:28329830 flutamide increases expression EXP 6480464 Flutamide results in increased expression of BCAR3 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1323277 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 formaldehyde decreases expression ISO RGD:36174057 6480464 Formaldehyde results in decreased expression of BCAR3 mRNA CTD PMID:20655997 , PMID:23416264 fulvestrant affects response to substance ISO RGD:36174057 6480464 BCAR3 affects the susceptibility to Fulvestrant CTD PMID:24169358 genistein decreases expression ISO RGD:36174057 6480464 Genistein results in decreased expression of BCAR3 mRNA CTD PMID:22228119 genistein increases expression ISO RGD:1323277 6480464 Genistein results in increased expression of BCAR3 mRNA CTD PMID:32186404 heme b increases expression ISO RGD:1323277 6480464 Heme metabolite results in increased expression of BCAR3 mRNA CTD PMID:19191707 isobutanol multiple interactions ISO RGD:36174057 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of BCAR3 mRNA CTD PMID:29432896 L-methionine multiple interactions ISO RGD:1323277 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of BCAR3 gene CTD PMID:20938992 lipopolysaccharide decreases expression ISO RGD:1323277 6480464 Lipopolysaccharides results in decreased expression of BCAR3 mRNA CTD PMID:25890327 menadione affects expression ISO RGD:36174057 6480464 Vitamin K 3 affects the expression of BCAR3 mRNA CTD PMID:20044591 metformin affects expression EXP 6480464 Metformin affects the expression of BCAR3 mRNA CTD PMID:25596134 methylmercury chloride decreases expression ISO RGD:36174057 6480464 methylmercuric chloride results in decreased expression of BCAR3 mRNA CTD PMID:28001369 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BCAR3 mRNA CTD PMID:22546817 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of BCAR3 mRNA CTD PMID:33484710 oxaliplatin multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in decreased expression of BCAR3 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:36174057 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of BCAR3 mRNA more ... CTD PMID:32699268 ozone increases expression ISO RGD:1323277 6480464 Ozone results in increased expression of BCAR3 mRNA CTD PMID:17095637 paracetamol increases expression ISO RGD:36174057 6480464 Acetaminophen results in increased expression of BCAR3 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BCAR3 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:36174057 6480464 Acetaminophen results in decreased expression of BCAR3 mRNA CTD PMID:25596134 paracetamol affects expression ISO RGD:1323277 6480464 Acetaminophen affects the expression of BCAR3 mRNA CTD PMID:17562736 paraquat increases expression EXP 6480464 Paraquat results in increased expression of BCAR3 mRNA CTD PMID:32680482 phenobarbital affects expression ISO RGD:36174057 6480464 Phenobarbital affects the expression of BCAR3 mRNA CTD PMID:19159669 piroxicam multiple interactions ISO RGD:36174057 6480464 Cisplatin affects the reaction [Piroxicam results in decreased expression of BCAR3 mRNA] CTD PMID:21858171 piroxicam decreases expression ISO RGD:36174057 6480464 Piroxicam results in decreased expression of BCAR3 mRNA CTD PMID:21858171 progesterone multiple interactions ISO RGD:36174057 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of BCAR3 mRNA CTD PMID:20660070 quercetin increases expression ISO RGD:36174057 6480464 Quercetin results in increased expression of BCAR3 mRNA CTD PMID:21632981 rac-lactic acid increases expression ISO RGD:36174057 6480464 Lactic Acid results in increased expression of BCAR3 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:36174057 6480464 [Coumestrol co-treated with Resveratrol] results in decreased expression of BCAR3 mRNA CTD PMID:19167446 rotenone increases expression EXP 6480464 Rotenone results in increased expression of BCAR3 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:36174057 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCAR3 mRNA CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:36174057 6480464 Asbestos, Serpentine results in decreased expression of BCAR3 mRNA CTD PMID:21148743 silicon dioxide increases expression ISO RGD:1323277 6480464 Silicon Dioxide results in increased expression of BCAR3 mRNA CTD PMID:19073995 more ... silicon dioxide increases expression ISO RGD:36174057 6480464 Silicon Dioxide analog results in increased expression of BCAR3 mRNA, Silicon Dioxide results in increased expression of BCAR3 mRNA CTD PMID:25351596 , PMID:25895662 silver atom decreases expression ISO RGD:1323277 6480464 Silver results in decreased expression of BCAR3 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1323277 6480464 Silver results in decreased expression of BCAR3 mRNA CTD PMID:27131904 sodium arsenate multiple interactions ISO RGD:36174057 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of BCAR3 mRNA CTD PMID:32525701 tamoxifen affects response to substance ISO RGD:36174057 6480464 BCAR3 protein affects the susceptibility to Tamoxifen CTD PMID:19075277 temozolomide increases expression ISO RGD:36174057 6480464 Temozolomide results in increased expression of BCAR3 mRNA CTD PMID:31758290 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BCAR3 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1323277 6480464 Carbon Tetrachloride results in decreased expression of BCAR3 mRNA CTD PMID:31919559 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of BCAR3 mRNA CTD PMID:34492290 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of BCAR3 mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in decreased expression of BCAR3 mRNA CTD PMID:25729387 trichostatin A multiple interactions ISO RGD:36174057 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCAR3 mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:36174057 6480464 trichostatin A results in increased expression of BCAR3 mRNA CTD PMID:24935251 , PMID:26272509 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of BCAR3 mRNA CTD PMID:30589522 trovafloxacin increases expression ISO RGD:1323277 6480464 trovafloxacin results in increased expression of BCAR3 mRNA CTD PMID:35537566 urethane increases expression ISO RGD:36174057 6480464 Urethane results in increased expression of BCAR3 mRNA CTD PMID:28818685 valdecoxib increases expression EXP 6480464 valdecoxib results in increased expression of BCAR3 mRNA CTD PMID:24136188 valproic acid increases expression ISO RGD:36174057 6480464 Valproic Acid results in increased expression of BCAR3 mRNA CTD PMID:24383497 , PMID:24935251 vancomycin increases expression ISO RGD:1323277 6480464 Vancomycin results in increased expression of BCAR3 mRNA CTD PMID:18930951 zoledronic acid decreases expression ISO RGD:36174057 6480464 Zoledronic Acid results in decreased expression of BCAR3 mRNA CTD PMID:25596134